Patients with systemic lupus erythematosus (SLE) present
Patients with systemic lupus erythematosus (SLE) present with various gastrointestinal symptoms. The symptoms are caused by not only the disease itself, but also complicated inflammatory bowel diseases, adverse effects of therapeutic agents, and infections due to therapy related immunosuppression. Therefore, the incidence of gastrointestinal problems varies with the methods of studies (1)
.
On the other hand, colon lesions are rarely found in SLE patients, as reported by Miyahara et al in the October issue (4). Multiple ulcers appear mainly in the rectum and sigmoid colon (5). The colon disease is more common in patients during the active stage than those in remission and can be the initial manifestation of SLE. Main symptoms include abdominal pain, diarrhea, and bloody stool. The symptomatic feature is indistinguishable from that in inflammatory bowel diseases, especially ulcerative colitis. Since ulcerative colitis is not an extremely rare complication in SLE patients (1), it is hard to determine whether the colon disease arises from SLE itself or concomitant ulcerative colitis. Furthermore, it is common that colitis precedes the onset of lupus symptoms (1). To this end, endoscopic examinations with histopathological evaluation are essential for the differential diagnosis. Sulfasalazine for the treatment of inflammatory bowel diseases is known as one of the causative agents of drug-induced lupus. Indeed, patients with inflammatory bowel diseases and inflammatory arthropathy who are treated with sulfasalazine often develop lupus signs and symptoms with emergence of disease-specific autoantibodies (6). In addition, cytomegalovirus enteritis is also another important differential diagnosis in patients receiving an intensive immunosuppressive therapy (7).
Because 
